Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo SmithKline U.S. Management Will Be Early Test Of Integration Process

Executive Summary

Glaxo SmithKline's U.S. management team is to be worked out during the merger integration process between the two companies.
Advertisement

Related Content

Glaxo SmithKline
Glaxo SmithKline
Glaxo SmithKline Taking Soft Merger Route: Will Start With Two U.S. Heads
Glaxo SmithKline Taking Soft Merger Route: Will Start With Two U.S. Heads
Glaxo SmithKline U.S. Marketing Could Reach 250,000 MDs In One Week
FTC Will Have Opportunity To Address Genomics In Review Of Glaxo/SB
Glaxo SmithKline U.S. Marketing Could Reach 250,000 MDs In One Week
Chiron Lands Lance As CEO; Biotech Firm Seeking To Sharpen Image
Chiron Lands Lance As CEO; Biotech Firm Seeking To Sharpen Image
Advertisement
UsernamePublicRestriction

Register

PS035479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel